Utility of testing for monoclonal bands in serum of patients with suspected osteoporosis: Retrospective, cross sectional study

British Medical Journal

Volumn 330, Issue 7495, 2005, Pages 818-820

  Abrahamsen, Bo ^a   Andersen, Ivan ^a   Christensen, Susanne S ^a   Madsen, Jonna Skov ^a   Brixen, Kim ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PARAPROTEIN; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BONE DENSITY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ELECTROPHORESIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; OSTEOPENIA; OSTEOPOROSIS; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SERUM; BLOOD; CHI SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDY; EVALUATION; MIDDLE AGED; PREDICTION AND FORECASTING; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOCLONAL GAMMOPATHIES, BENIGN; MULTIPLE MYELOMA; MYELOMA PROTEINS; OSTEOPOROSIS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 17244365821     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.38376.401701.8F     Document Type: Article

References (14)

1. Nordic Myeloma Study Group. Vårdprogram for myelomatose. www.nordic-myeloma.org (accessed 1 December 2004).
2. Cancer incidence in Denmark 1999. Copenhagen: National Board of Health, 2003.
3. Altai M, Harousseau JL, Stoppa AM, Sotto J, Fuzibet JG, Rossi JF, et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med 1996;335:91-7.
4. Blade J, Munoz M, Fontanillas M, San Miguel J, Alcala A, Maldonado J, et al. Treatment of multiple myeloma in elderly people: long-term results in 178 patients. Age Ageing 1996;25:357-61.
5. Oken MM, Harvington DP, Abramson N, Kyle RA, Knospe W, Glick JH. Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479. Cancer 1997;79:1561-7.
6. Genvresse I, Lange C, Schanz J, Schweigen M, Harder H, Possinger K, et al. Tolerability of the cytoprotective agent amifostine in elderly patients receiving chemotherapy: a comparative study. Anticancer Drugs 2001; 12:345-9.
7. Genvresse J, Wedding U, Bokemeyer C, Spath-Schwaibe E. [Treatment of multiple myeloma in elderly patients: consensus of the Geriatric Oncology Working Group of the German Society of Hematologic Oncology and the German Society of Geriatrics]. Onkologie 2001;24:386-90.
8. Gregersen H, Mellemkjaer L, Ibsen JS, Dahlerup JF, Thomassen L, Sorensen HT. The impact of M-component type and immunoglobulin concentration on the risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance. Haematologica 2001;86:1172-9.
9. Sim MF, Stone M, Johansen A, Ho P, Pettit RJ, Evans WD. An analysis of an open access general practitioner bone densitometry service. Int J Clin Pract 2004;58:300-5.
10. Nelson DA, Molloy R, Kleerekoper M. Prevalence of osteoporosis in women referred for bone density testing: utility of multiple skeletal sites. J Clin Densitom 1998;1:5-12.
11. Ben Sedrine W, Broers P, Devogelaer JP, Depresseux G, Kaufman JM, Goemaere S, et al. Interest of a prescreening questionnaire to reduce the cost of bone densitometry. Osteoporos Int 2002;13:434-42.
12. Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 2003;78:21-33.
13. Roux S, Bergot C, Fermand JP, Frija J, Brouet JC, Mariette X. Evaluation of bone mineral density and fat-lean distribution in patients with multiple myeloma in sustained remission. J Bone Miner Res 2003;18:231-6.
14. Abildgaard N, Brixen K, Kristensen JE, Vejlgaard T, Charles P, Nielsen JL. Assessment of bone involvement in patients with multiple myeloma using bone densitometry. Eur J Haematol 1996;57:370-6.